In his talk, he noted that MTHFD2 is highly expressed in rapidly replicating tumor cells but not in normal adult tissues, providing a strong rationale for targeting this enzyme for selective cancer treatment (see Fig. 1 right side). This evidence concerns the gene MTHFD2 and cancer.